Apple proposes a lawsuit for violating intellectual property for hours of the heartbeat

Apple does not have to face a lawsuit claiming that his smart watch has copied the heart business of “Alivecor”, which is supported by the “Khosla Ventures LLC” business, according to a federal judge. US BooKotregter Jeffrey White in Auckland, California, issued a ruling to Apple on Tuesday, and the details of the decision were placed under the seal of the court due to confidential concerns by companies. A revised version will be published in the coming weeks. Apple said in a statement: “The lawsuit filed by the Apple Company is challenging Apple’s ability to improve the important capabilities of the Apple Watch on which consumers and developers depend on, and confirm today that it is not a hindrance to competition.” The company “Alevkour” said it was “deeply disappointed” about the decision and plans to appeal. She added in a statement: “We will continue to strongly protect our intellectual property to benefit our clients and improve innovation.” The conflict is based on a meeting held in 2015, when David Albert, co -founder of the “Alevkor”, was invited by Apple Ceos to display his heart monitor, called ‘Cardiaband’. The ‘Alevkour’ claims that Albert was told that the ‘iPhone’ manufacturer intends to work on this technology. Apple said the meeting over the years was like hundreds of other meetings that offered it with developers, without any claim to partnership. According to the complaint, after 18 months of discussions between the two companies and in a ‘clear attempt to steal the lights of (Effor),’ a few hours after giving the ‘Apple’ watch ‘watch’ watch, which he notified the ‘Apple’. Over the next few years, when Apple updated the WTS operating system, no other service was allowed to provide the heart stroke monitoring on the device because of the ‘concentrated campaign conducted by the company to monopolize the market’, according to the ‘Alevkour’ claimed in its complaints to combat monopoly. Apple has denied this claim, saying that since 2015 it has allowed the third -party applications to use the cardiovascular sensor technology. The Alevkour said that the separate patent calls against Apple are still under litigation.